Dr. Fernando de la Calle
Head of Microbiology Dpt. PharmaMar. Madrid. Spain
Biography
Head of the Microbiology Dpt .at PharmaMar where he joined 30 years ago. He received his Ph.D. in Molecular Biology from UAM (Madrid) in 1998. He also completed an Executive-MBA in 2005. Co-author of the current hemisynthetic process for manufacturing the anticancer Yondelis®, the first European marine derived compound approved. He has been member of the International Advisory Group of ERA-MBT and BiodivERsA. Reviewer for H2020, FP7 and ERA-NET projects. He is the scientific contact person from PharmaMar for FP7/H2020 EU projects related to Marine Biodiversity & Biotechnology such as MAMBA, MaCuMBA, MicroB3 and INMARE.
Abstract
Abstract : Marine Microbiome and Drug Discovery